News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
221 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (22984)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (31)
2 (29)
3 (279)
4 (239)
5 (185)
6 (219)
7 (134)
8 (5)
9 (2)
10 (218)
11 (255)
12 (223)
13 (194)
14 (151)
15 (4)
16 (14)
17 (221)
18 (253)
19 (211)
20 (239)
21 (133)
22 (2)
23 (4)
24 (22)
25 (1)
26 (55)
27 (85)
28 (60)
30 (1)
31 (34)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
30
31
FDA
Celltrion and Teva Snag Second Biosimilar Approval of a Genentech Drug
The U.S. Food and Drug Administration approved another biosimilar. On Friday, the regulatory agency approved Herzuma, a biosimilar to Genentech’s Herceptin developed by South Korea-based Celltrion, Inc. and Israel-based Teva Pharmaceuticals.
December 17, 2018
·
2 min read
·
Alex Keown
Business
Genentech Licenses Non-CF Compound From Proteostasis in $100 Million-Plus Deal
Proteostasis Therapeutics, based in Boston, signed a worldwide, exclusive license deal with Genentech for rights to a possible small molecule modulator within the proteostasis network.
December 17, 2018
·
2 min read
·
Mark Terry
Drug Development
HIV Vaccine in Monkeys Suggests Human Vaccine on the Horizon
So far, a vaccine for HIV has been elusive. However, researchers with Scripps Research Institute recently published positive data about its HIV vaccine in the journal Immunity that suggests one might be on the horizon.
December 17, 2018
·
2 min read
·
Mark Terry
Policy
New Industry Report Finds Most Orphan Drugs Aren’t Successful
Generally speaking, the Orphan Drug Act has worked. More companies are willing to invest the millions of dollars needed to develop a drug that has a very small market.
December 17, 2018
·
3 min read
·
Mark Terry
Business
Commemorating a quarter century as a continuing partner of St. Jude Children’s Research Hospital®, National Beverage Corp. (NASDAQ:FIZZ), implores all to join its mission to provide miracles for children stricken with life-threatening illnesses.
Horizon Discovery Group plc (AIM: HZD), a global leader in the application of gene editing and gene modulation technologies, today announces that it has entered into an exclusive target discovery partnership with C4X Discovery Holdings plc (AIM: C4XD)(“C4XD”), a pioneering drug discovery company.
December 17, 2018
·
6 min read
Ministry of Health and Prevention announces Al Qassimi Hospital in Sharjah awarded international accreditation by JCI
UAE remains number 1 globally with highest number of accredited health facilities
December 17, 2018
·
4 min read
Flu vaccinations can work as effectively in the active healthy elderly compared to the young
Clinical trial results also suggest that immune responses to flu vaccinations in independent elderly individuals are not affected by their levels of frailty
December 17, 2018
·
7 min read
Business
Arrogance, Ambition and Sloppiness: More Details Behind the CRISPR Babies Story
In an in-depth investigation, STAT reported on behind-the-scenes activities at the Second International Summit on Human Genome Editing at the University of Hong Kong, where He made his announcement.
December 17, 2018
·
4 min read
·
Mark Terry
Business
Seer Launches to Develop Protein-Based Liquid Biopsies
Yet another company has launched to develop liquid biopsies. Founded and headed by Omid Farokhzad, formerly a professor at Brigham and Women’s Hospital, Seer is based in San Francisco.
December 17, 2018
·
2 min read
·
Mark Terry
Policy
More Woes Continue for J&J and Its Iconic Talc Product as Report Details a History of Contamination
A Reuters analysis of company documents reveals that Johnson & Johnson knew about levels of asbestos contamination in its talc products, but did not report it to the FDA.
December 17, 2018
·
3 min read
·
Alex Keown
1 of 23
Next